A study led by Cedars-Sinai investigators uncovered a significant uptick in chronic digestive disorders, like irritable bowel syndrome, during the COVID-19 pandemic.

A 14-month randomized trial in older African American adults with obesity found that adopting a Mediterranean diet, with or ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The new drug may rival other weight loss medications such as Ozempic and Mounjar ...

Use of the drugs for weight loss alone will no longer be covered for patients who ... Pennsylvania has surplus cash in the bank, roughly $11 billion built up due to pandemic-era federal aid. But the ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

That claim from the Noom app — that it isn’t a diet, yet can achieve long-lasting weight loss — surely encouraged some of its 45 million downloads in the first five years since it was launched.

COVID-19 pandemic stress caused woman to gain weight. She joined the weight loss app Lose It! and counted calories to lose 75 pounds and improve energy.